Mitotic kinesin inhibitors
US7745639B2 · kind B2 · utility
0Cited by
3References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 4, 2003 |
| Grant date | Jun 29, 2010 |
| Priority date | — |
| Expiry date | Jun 18, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.